You are here: Home » Markets » News
Business Standard

Lupin's 4.5% rise pushes Nifty Pharma index up by 1.5%

Nifty Pharma gained over 1.5% today, making it the top performing index among other sectora

SI Reporter  |  New Delhi 

pharma, pharma industry
Govt proposes to bring fixed-dose combinations under price control

Pharma stocks were in focus in today’s trade with surging as much as 4.7%, becoming the biggest gainer on both the frontline indices.
The pharma major helped gain over 1.5% in today’s trade, making it the top performing index among other sectoral indices. index also gained 1.4%.

In the month of June, Nifty Phrma rallied over 6%, a change of pace from the 11% fall in May 2017. The index has been up 1.6% in July so far but is down 6.5% in 2027 till date.
Followed by Lupin, shares of Divis Lab was trading higher by 2%, Dr Reddy’s advanced 2%, rose 0.5% and was up by 1.4%
At 11:04 am was currently trading at Rs 1126, up by Rs 45 or 4.15% from its previous closing of Rs 1081.25 on the BSE.
The scrip opened at Rs 1089.7 and has touched a high and low of Rs 1,132 and Rs 1,085 respectively. So far 14,62,349 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 48,842.65 crore.